Long-term cannabis user reflects on adolescent risks of early marijuana use

Twenty years of smoking cannabis leaves a person with a particular kind of clarity—the sort that comes too late. A long-term user, now reflecting on the arc of their own consumption, traces the line backward to age thirteen, to the moment before daily use became simply the shape of their life. The regret isn't theatrical. It's the quiet kind that settles when you understand what you didn't know then: that the brain doesn't finish developing until the mid-twenties, and that cannabis during those formative years isn't a harmless experiment but a choice with measurable consequences.

The science has accumulated steadily. Adolescents who develop cannabis use disorder face significantly elevated risks of psychiatric illness later in life—depression, anxiety, psychosis, and other conditions that can persist for decades. This isn't speculation or moral panic. Brain imaging studies show tangible changes in users who consume cannabis daily during their teenage years. The developing adolescent brain is particularly vulnerable. It's still wiring itself, still establishing the neural pathways that will govern mood regulation, impulse control, and stress response. Cannabis interferes with that process in ways that can't simply be undone by stopping use.

What makes this moment in public health particularly fraught is the gap between legalization and safety. In jurisdictions where cannabis is now legal, the messaging has often centered on what the drug isn't—it isn't heroin, isn't cocaine, isn't alcohol in terms of overdose risk. But legality has created a kind of cultural permission that obscures a harder truth: legal doesn't mean harmless, especially not for young people whose brains are still under construction. A teenager in a state where cannabis is sold in dispensaries with the same casual accessibility as coffee faces the same neurological risks as one in a place where it remains prohibited. The law has changed. The biology hasn't.

The personal testimony of someone who spent two decades as a regular user carries weight precisely because it comes without the distance of abstraction. This person lived inside the choice, day after day, year after year. They can speak to what daily use actually feels like, how it reshapes your relationship to motivation and memory, how it can become so woven into your identity that you forget there was ever a version of yourself that didn't need it. And they can look back at thirteen—at the moment before any of that began—and articulate what they wish they'd understood: that starting young isn't just starting early. It's starting during the window when the damage is most likely to be permanent.

The public health challenge now is to build messaging that acknowledges this reality without relying on the scare tactics that failed for previous generations. Young people can smell dishonesty. They know that cannabis isn't the demon it was portrayed as in the 1980s. But that doesn't mean the risks aren't real. The conversation needs to be more sophisticated: yes, cannabis exists on a spectrum of harm. Yes, some people use it without developing serious problems. And yes, for adolescents—for brains still in the process of becoming—the calculus is different. The stakes are higher. The window for prevention is narrower and more consequential than it is for adults.

What a long-term user wishes they'd known at thirteen is what we're only now learning to articulate clearly: that legalization and safety are not the same thing, that adolescence is a uniquely vulnerable period, and that the choice to use cannabis at that age is a choice with a particular weight. The person reflecting on twenty years of use isn't arguing for prohibition or moral judgment. They're simply pointing out what the evidence now shows—that early use carries costs that compound over time, and that the younger you start, the more likely those costs will be psychiatric, cognitive, and lasting.